Monday 14 March 2016

LYSINE MARKET RESEARCH REPORT

Report on Lysine gives a market insight into various applications of Lysine in Feed Additives, Food & Dietary Supplements, Pharmaceuticals and Other segments. The report serves as a guide to the global Lysine industry, covering more than 400 companies that are engaged in production and processing of raw material or end use product. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to Lysine is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, China, Asia-Pacific, and Rest of World with 121 exclusive graphically represented exhibits.

Request sample of this report @
https://www.researchimpact.com/global-market-research-reports/report.php?link=lysine

Global Lysine market is projected to grow at 9.5% annually through 2010 - 2022. Today amino acids can be taken as a supplement that is available commercially. Amino acid supplements are usually made from animal protein, vegetable protein, or yeast. While almost all amino acids can be produced in two forms, L and D form. There has been a substantial increase in the demand for amino acids in the last thirty years or so. There is a steady 5-10% growth rate in the market. It is estimated that in that last ten years the market demand for amino acids has doubled. L-lysine, which is used as an additive in animal feed, has shown a sharp increase in demand. It is estimated that the global market for L-lysine has increased almost 20 times in the past twenty years. Among the amino acids available in the market, L-Glutamate is still the most popular one followed by L-lysine and D, L-methionine. The prices of amino acids are often affected by the dynamics in the market. The increase in the efficiency of the fermentation technology can lead to the development of cheaper goods and thereby increase the overall demand. Subsequently, there is bound to be large-scale production of these products which will lower the costs even more. However, despite these trends in the market, the supply of amino acids such as L-lysine to be used as feed additives will compete with soybean meal which is a natural source of L-lysine. Amino acids continue to command a large market share, and continue to grow. The packaged food industry is now becoming the major user of amino acids, and the demand from society remains strong for such food supplements. Amino acids are now being used in many forms including health-food drinks, body building supplements, and even nutrients in the intravenous feeding and maintenance products.

Enquiry about this report @
https://www.researchimpact.com/global-market-research-reports/report.php?link=lysine


For more information please contact us - contactus@researchimpact.com

Know RI Technologies @
Anasuya Vemuri
Research Impact Technologies
Tel+91 9676994272
Email: contactus@researchimpact.com
www.researchimpact.com

Wednesday 9 March 2016

Arginine Market Research Report

Market research report on Arginine, emphasizes on both, its type and application areas. The major types analyzed include for L-Arginine, L-Arginine Monohydrochloride, D-Arginine and Other Arginine; and the major application areas encompass Nutraceuticals, Pharmaceuticals, Personal Care and Other applications (Pet Foods, Fertilizers & Chemical Reagents). The markets are analyzed both in Value (US$) and Volume (Metric Tons). The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists more than 500 companies that are engaged in Arginine production/manufacture and processing of raw material or end use products . Estimations and predictions are graphically represented by region, by type and by application segment. Compilation of Worldwide Patents and Research related to amino acids and arginine are also presented. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific and Rest of World. Estimations and predictions are graphically illustrated for 211 exclusive exhibits for all geographic regions.

Request sample of this report @

Global Arginine market is projected to grow at 3% annually through 2010 - 2022. Today amino acids can be taken as a supplement that is available commercially. Amino acid supplements are usually made from animal protein, vegetable protein, or yeast. While almost all amino acids can be produced in two forms, L and D form. There has been a substantial increase in the demand for amino acids in the last thirty years or so. There is a steady 5-10% growth rate in the market. It is estimated that in that last ten years the market demand for amino acids has doubled. The increase in the efficiency of the fermentation technology can lead to the development of cheaper goods and thereby increase the overall demand. Subsequently, there is bound to be large-scale production of these products which will lower the costs even more.

Enquiry about this report @

For more information please contact us - contactus@researchimpact.com

Know RI Technologies @


Anasuya Vemuri
Research Impact Technologies
Tel: +91 9676994272
Email: contactus@researchimpact.com
www.researchimpact.com

Thursday 3 March 2016

Regulatory Authorities require drug testing of known ion channels, especially hERG, to rule out possible side effects before clinical trials are performed.



Introduction of a new drug in the market is not only expensive but also an extremely complicated process. The process of drug discovery is fraught with several risks. The number of new drug launches each year has remained relatively constant over the past few years; whereas, the cost of pharmaceutical research and development has sky-rocketed. This reveals that the success rate of a drug candidate overcoming the several hurdles is at best 1 in 10. Advanced technologies, superior R&D facilities have not greatly contributed to the success rates of lead compounds in drug discovery. Also, the concerning factor is that most drug candidates in development on which large investments have already been made have little probability of returning. ADMET (absorption, distribution, metabolism, excretion and toxicology) profiles of drug candidates are the stumbling blocks.

Along with the FDA, all countries have stringent rules for drug introductions. In this wake, the regulatory authorities are paying great emphasis on testing of all new drugs on hERG channels for side effects. Consequently, a lot number of whole cell recordings is performed on these grounds. hERG Screening has attracted great attention due to its role in cardiac arrhythmia and the LQT-syndrome.

RI Technologies' market research report on hERG Screening gives an insight into the hERG Screening market and its impact on drug development and discovery. The study provides global market analysis for hERG Screening for sensitivity of potassium ion channels towards drugs. The study emphasizes on both technology and product segments of hERG Screening in biotechnology and pharmaceutical application areas. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists more than 190 companies that are engaged in hERG Screening services and/or production of hERG screening tools/instruments. A global perspective is presented along with regional analysis covering North America, Europe, Asia-Pacific and Rest of World. Compilation of Worldwide Patents and Research related to hERG Screening is also provided.

hERG - which encodes the potassium ion channel is considered responsible for repolarizing IKr current in the cardiac action potential. Screening of new drug candidates for fatal side-effects on cardiac ion channels has led to increased efficient electrophysiological testing with higher throughput than is possible with conventional patch-clamp.Cardiovascular safety liabilities cause major drug attrition rates during preclinical and clinical development, adverse drug reactions, and post-approval withdrawal of medicines. As per pharmaceutical industry surveys, the last decade has seen a significant fall in the number of new medicines being launched inspite of significant investments in Research and Development. Non-clinical and clinical safety has remained a major cause of drug attrition. Such attrition may take place either in preclinical or clinical development or post-approval stages, resulting in withdrawal of marketed drugs. This accounts for about one-third of all drug discontinuation.

Cardiovascular toxicity is happening more frequently than hepatotoxicity. Cardiovascular safety liabilities assume paramount importance in view of these findings in contemporary drug development activities.A very vibrant market exists for pharma companies, biotech companies, service providers and CROs. The relevance of hERG to toxicity of several pharmaceutical drugs makes it imperative that all compounds entering clinical stage are compulsorily checked for hERG activity. The FDA has passed strict laws for this important requirement. Genetic studies have added to the importance of ion channels and their significance in drug discovery and development.

For more information please contact us - contactus@researchimpact.com

About RI Technologies
Research Impact Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.Anasuya Vemuri

Anasuya Vemuri
Research Impact Technologies
Tel +91 9676994272
Email: contactus@researchimpact.com
www.researchimpact.com

Wednesday 3 February 2016

AMINO ACIDS - CRITICAL TO LIFE - RI TECHNOLOGIES' EXHAUSTIVE MARKET RESEARCH ON TYPES AND APPLICATION AREAS

Market Research with Focus on Arginine, Aspartic Acid, Glutamic Acid, Glycine, Lysine, Methionine, Phenylalanine, Threonine, Tryptophan
RI Technologies' exclusive portfolio of Amino Acids market research reports emphasizes on the growing importance of market dynamics of global amino acids market. The production of amino acids in laboratories using different biotechnological techniques marks the development and coordination of science and technology. The demand for amino acid production is huge and constant improvement in the field is always desired for cost effective and high yield production strategies. New findings such as the existence of specific export carriers or cyclic fluxes within the anapleurotic reactions are to be exploited maximum for better production of amino acids. The strain development, the fermentation process and the new science of metabolic engineering are to be closely coordinated for the advantageous production of amino acids from available sources.

There has been a substantial increase in the demand for amino acids in the last thirty years, with market demand for amino acids doubling in the last ten years. L-lysine, which is used as an additive in animal feed, has shown a sharp increase in demand. It is estimated that the global market for L-lysine has increased almost 20 times in the past twenty years. There are other amino acids that are now available in the market such as L-threonine, L-aspartate and L-phenylalanine. Specifically, L-aspartate and L-phenylalanine are used for the synthesis of a sweetener known as Aspartame.Among the amino acids available in the market, L-Glutamate is still the most popular one followed by L-lysine and D, L-methionine.

The prices of amino acids are often affected by the dynamics in the market. The increase in the efficiency of the fermentation technology can lead to the development of cheaper goods and thereby increase the overall demand. Subsequently, there is bound to be large-scale production of these products which will lower the costs even more. However, despite these trends in the market, the supply of amino acids such as L-lysine to be used as feed additives will compete with soybean meal which is a natural source of L-lysine. Therefore, there are bound to be fluctuations in the market demand for amino acids based on the yield of crops. The quantity of production of amino acids is also a determinant of its cost. Amino acids that are produced on a large-scale are bound to be less in cost. The price factor also plays a role in the location of the production plants. The location of the production plants is governed by the chief dynamics of price of the carbon source and the local market. There are large L-glutamate production plants in different parts of the world specifically in the countries of the Far East such as Thailand and Indonesia. However, as far as the location of the production plants of L-lysine are concerned, the situation is different. Since one-third of the global market for this product is concentrated in North America, one-third of the L-lysine production plants are located there. The location of these plants in this area is also driven by the availability of maize as a feedstock material for the process of fermentation. Most of the time, the companies that are producers of L-lysine are linked to the maize milling industry in various capacities either as producers, in joint ventures or as suppliers of cheap sugar. This is indicative of the fact that commercialization of amino acid production is undergoing rapid change and growth under the influence of the various global interactions.
Know More about the Reports - 
Unnatural Amino Acids - https://www.researchimpact.com/global-market-research-reports/report.php?link=unnatural-amino-acids

D-amino Acids - https://www.researchimpact.com/global-market-research-reports/report.php?link=d-amino-acids

Arginine - https://www.researchimpact.com/global-market-research-reports/report.php?link=arginine

Aspartic Acid - https://www.researchimpact.com/global-market-research-reports/report.php?link=aspartic-acid

Glutamic Acid - https://www.researchimpact.com/global-market-research-reports/report.php?link=glutamic-acid

Glycine - https://www.researchimpact.com/global-market-research-reports/report.php?link=glycine

Lysine - https://www.researchimpact.com/global-market-research-reports/report.php?link=lysine

Methionine - https://www.researchimpact.com/global-market-research-reports/report.php?link=methionine

Phenylalanine - https://www.researchimpact.com/global-market-research-reports/report.php?link=phenylalanine

Threonine - https://www.researchimpact.com/global-market-research-reports/report.php?link=threonine

Tryptophan - https://www.researchimpact.com/global-market-research-reports/report.php?link=tryptophan
Beauty products are increasing their demand for incorporation of amino acids as more and more people are making use of amino acids to maintain their figure and body fitness. There is an increasing trend at present to incorporate amino acids in body soaps, rinses and shampoos. Such products that contain amino acids do certainly have advantages to improve the general fitness of the body.

Amino acids continue to command a large market share, and continue to grow. The packaged food industry is now becoming the major user of amino acids, and the demand from society remains strong for such food supplements. Amino acids are now being used in many forms including health-food drinks, body building supplements, and even nutrients in the intravenous feeding and maintenance products.

For more information please contact us - contactus@researchimpact.com

Anasuya Vemuri
Research Impact Technologies
Tel +91 9676994272 
Email: contactus@researchimpact.com
www.researchimpact.com

Wednesday 27 January 2016

Global Blood Components, Testing and Collection Market Spurred by Sudden Increases in New Infections

With consumers insisting on zero-risk blood supply, large investments are being put into development of pathogen reduction solutions.
Viral inactivation technologies for blood constituents will stimulate the next phase of development in the blood banking systems and plasma products market.
— Anasuya Vemuri
HYDERABAD, TELANGANA, INDIA, January 27, 2016 /EINPresswire.com/ -- RI Technologies' market research report on Blood – Components, Testing & Collection gives an insight into different areas including Blood Products, Blood Banking Devices (Such as Equipment involved in Collecting, Processing and Storing Blood and Blood Components), Blood Testing and Other (Such as Artificial Blood, Cord Blood and Recombinant Factors). Blood Products include Cellular Blood Components, Whole Blood and Plasma Derived Products (Immunoglobulins, Coagulation factors, Alpha-1 proteinase inhibitors, Albumins, Fibrin and Anti-Coagulants). Blood Testing includes Immunoassays, NAT and Other. The report provides an in depth analysis of each of the type and product areas by their respective categories. The study includes estimates and projections (2005 - 2020) for the total global Blood Research and Products market and also key regional markets that include North America, Europe, Japan, Asia-Pacific and Rest of World. 

This study is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in --
* Gauging Competitive Intelligence
* Identifying Key Growth Areas and Opportunities
* Understanding Geographic Relevance to Product
* Knowing Regional Market Sizes and Growth Opportunities and Restraints
* Keeping Tab on Emerging Technologies
* Tapping New Markets

Demand for blood products is set to rise in developed as well as developing countries due to aging population that needs sophisticated testings and intricate operations as well as rapid advancement and ready availability of advanced technologies. Hemoglobin-based oxygen carriers (HBOCs) and PFC-based products also may provide significant growth to the market. Even though people are now alert to the different infections, the industry is yet to overcome difficulties such as security, and the accessibility to good quality blood. This has led to very strict safety measurements being taken for both the donors as well as the blood banks which have to be adhered to before any transfusion is carried out. The risk of diseases spread through transfusions has decreased due to conduction of thorough testing and screening techniques and also with the assistance from latest technologies. Current conversion rates from plasma-derived to recombinant factor products are increasing the standard factor product cost. Collecting blood manually continues to be the most productive technique for collecting blood and the systems that are used in these procedures are extremely important to the blood banking industry.

Blood banks now readily await a safe technology that will combine with their processing systems and decrease the danger of transfusion-related infections to almost nil. The success of the market is ascertained by the capacity to provide cost-effective technologies with a wide kill range, strong safety profile and the effortlessness in the application. The provision to persuade the buyer decision making processes combined with first-mover advantage will be significant in achieving a competitive edge. The market will observe a strong operation towards combining device production knowledge and biopharmaceutical technology, as companies work towards producing safer blood collection techniques and blood replacements.

To order this market research report on Blood – Components, Testing & Collection, please contact us at contactus@researchimpact.com. You may also explore custom research services on Blood – Components, Testing & Collection with RI Technologies. 


About RI Technologies

Research Impact Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.
Anasuya Vemuri
Research Impact Technologies
+91 9676994272

Wednesday 30 December 2015

Unnatural Amino Acids - Increasing Applications in Pharmaceuticals

RI Technologies' market research study on Unnatural Amino Acids - market is driven by derivatives that find large applications in pharmaceuticals.
Optically clean unnatural amino acids are becoming more and more significant as pharmaceutically active compounds.
— Anasuya Vemuri
HYDERABAD, TELANGANA, INDIA, December 30, 2015 /EINPresswire.com/ -- RI Technologies' market researchreport on Unnatural Amino Acids gives a market insight into the different types of Unnatural Amino Acids (β-Amino Acids, β-Amino Acid Derivatives, Cyclic Amino Acids & Derivatives, D-Amino Acids, D-Amino Acid Derivatives, DL-Amino Acids, DL-Amino Acid Derivatives, L-Amino Acid Derivatives and Other ) and their application areas such as R&D, Pharmaceutical, Food & Feed, Agrochemicals and Other applications.
The study includes estimates and projections for the global Unnatural Amino Acids by type and applications. Regional Analysis is covered separately for North America (United States and Canada); Europe (UK, Germany, Switzerland, Italy, The Netherlands, and Rest of Europe; Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific); and Rest of World.

Business profiles of 57 major companies are discussed in the report. The report serves as a guide to global Unnatural Amino Acids industry covering more than1000 companies that are engaged in Unnatural Amino Acids R&D, synthesis, discovery, testing and supply of derivatives, products and services. Information related to industrial activity, corporate developments, research trends, product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.

Research - As Good as the Methodology is!

Development of selective peptide receptor ligands with orally administered drug properties has progressed rapidly in the past decade. Non-natural amino acids are accepted major tool to prepare peptide ligand mimetics with superior biological activity and proteolytic resistance. Non-natural amino acids have applications as pharmacologically active products, molecular scaffolds, conformational constraints and building blocks. They embody an almost countless array of different structural elements to develop new therapeutic drugs. In the field of pharmaceuticals, unnatural amino acids are found to have a very important role to play. Chiral amines also have an industrial significance and importance in the fine chemical arena and this is because of their use as resolving agents, catalysts for asymmetric synthesis, and chiral bases.

About 18% of the leading drugs and agrochemicals include amino acids in their synthesis. Unnatural amino acids can make proteins 30 times more effective in treating cancer. For example, L-Homophenylalanine is an unnatural amino acid and is an effective drug for the therapy of hypertension and congestive heart diseases. Diagnostic / Therapeutic medicine are the important application area of unnatural amino acids.

Owing to the growing importance of unnatural amino acids as pharmaceutical intermediates, a range of methods are being developed for their enantiomerically pure preparation. Regularly employed processes consist of resolutions by diastereomeric crystallization, enzymatic resolution of derivatives, partition by simulated moving bed (SMB) and chiral chromatography. These methods are adopted to separate racemic mixtures but the highest hypothetical yield is expected to be around 50%.

For non-proteinogenic L-amino acids such as L-nor-valine, L-nor-leucine, L-2-amino-5-[1-3], dioxolan-2-yl-pentanoic acid, L-tert-leucine and others; the preferred method for their synthesis is enzymecatalyzed reductive aminations.
Optically clean unnatural amino acids are becoming more and more significant as pharmaceutically active compounds. Chiral directing auxiliaries, and chiral synthons are widely being used in organic synthesis. The use of D-amino acids in the production of semi-synthetic antibiotics is increasing very fast and is being widely preferred. The drugs - ampicillin and amoxicillin - are produced using D-phenylglycine and p-hydroxy-Dphenylglycine respectively. These drugs are found to be broad-based and more stable compared to enzymatic degradation than naturally occurring (benzyl) penicillin. The production quantity of p-Hydroxy-D-phenylglycine ranges in several kilotons per year.

For more information please contact us - contactus@researchimpact.com

About RI Technologies

Research Impact Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.


Research Impact Technologies
Tel +91 9676994272 
Email: contactus@researchimpact.com
Anasuya Vemuri
Research Impact Technologies
+91 9676994272
email us here

Friday 4 December 2015

Biologics - Shaping the Future of Drug Discovery and Development

Biologics for rheumatic diseases, which focus on molecules concerned with the techniques connected with immune systems, offer a good option to the current treatment procedures for autoimmune diseases.
Research Impact Technologies' latest update on Biologics market provides an exclusive insight into this field of complex medications. Global Biologics market is projected to grow at 9.33% compounded annually from 2005 through 2020. Blood and blood products are the major product area with tremendous potential and growth. Automated blood collection and processing systems as well as prior-screening capabilities of latest assays are expected to enhance quantity and quality of blood. Since the last decade, the therapeutic market for monoclonal antibodies has grown exponentially. Bevacizumab, Trastuzumab, Adalimumab, Infliximab and Rituximab are the top five therapeutic antibodies available. About 40% of the best selling biopharmaceuticals are therapeutic monoclonal antibodies. Development of vaccines has proved to be crucial and effective in the pharmaceutical industry. Growing human and animal populations and advancement of science and technology are the driving factors behind the global vaccines market. High prevalence of diabetes, treatment and diagnosis rates, device penetration and changes in price are driving the human insulin market. Biologics market holds tremendous potential and promise. 

Since the approval of insulin as the first recombinant therapeutic protein, biologic therapies in drug development have gained immense significance. Biologics have delivered life changing results. Many unmet medical needs are being addressed for several disease areas using traditional replacement proteins to more recent, highly engineered antibodies, oligonucleotides, fusion proteins, and gene constructs. 

The market study analyzes the Biologics market by product type, application area and by disease area. Product types include Monoclonal Antibodies, Blood & Blood Products, Vaccines, Insulin and Other, while application areas are for both human and animal consumption. The disease areas covered include autoimmune diseases, oncology, infectious Diseases, Diabetes and other. The report serves as a guide to Biologics market, covering more than 800 companies that are engaged in Biologics products and services. Major Contract Research Organizations, Research Institutes and Universities serving the Biologics market are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to Biologic products is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, and Rest of World with more than 150 exclusive graphically represented exhibits.

This report may help Drug Developing Companies, Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for Products
Identify Competition
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information


To order this market research report on Biologics, please contact us atcontactus@researchimpact.com. You may also explore custom research services on Biologics with RI Technologies. 


About RI Technologies

Research Impact Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.


contactus@researchimpact.com
Anasuya Vemuri
Research Impact Technologies
+91 9676994272

Wednesday 4 November 2015

Identify Market Opportunities, Know Competition, Get Actionable Information

Research Impact Technologies' life science reports are unique in their market analysis and business forecasts, providing invaluable market and company insights.
Research Impact believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data.
— Anasuya Vemuri
HYDERABAD, TELANGANA, INDIA, November 4, 2015 /EINPresswire.com/ -- Research Impact Technologies has announced discounts on its portfolio of Biotech, Medical & Life Science Market Research Reports. The strategic market information tables, graphically represented, greatly aid research needs and help in forecasting, and gearing up to the future, armed with qualitative research. This will significantly reduce risks of new product development and will give a global vision and perspective to company products. Several data tables, charts, and graphs complement the text. Exclusive market numbers are provided for several hard to find niche markets.

Research Impact believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information that will help companies probe into and support critical business decisions.


Diligent market research reports featuring several market data dynamics may help companies to -
o Identify Market Opportunities
o Review and Analyze Global and Regional Markets
o Gauge Market Potential
o Identify Competition
o Acquire Meaningful Guidelines for Strategic Planning
o Gear up for Market Entry


Niche Biotechnology, Medical, Life Science Related Studies

ADME/Tox Technologies
High Throughput Screening
Biomarkers
Metabolomics
Stem Cells - Types, Technologies & Therapeutics
RNAi
Angiogenesis Modulators
Apoptosis
Chiral Chemicals
Biological Implants
Bionanotechnology
Biochips
hERG Screening
DNA Sequencing
Intravenous Solutions
Amino Acids
Glucosamine
Biotechnology in India
Prions
Bio Imaging
Veterinary Vaccines
Biopesticides
GPCR - Drug Targets
Stem Cell Research in Cardiology
Tissue Sealants
Feed Nucleotides
Unnatural Amino Acids
Liposomes
Blood - Components, Testing and Collection
Polylactic Acid
Lactic Acid
D-Amino Acids
Polyethylene Glycol Dimethyl Ether (PEG DME)
Biosensors
Biodegradable Stents
Circulating Tumor Cells (CTC) Technologies
Bioinformatics
Ethanol
Biologics
Security Technologies in Biotechnology
Polyols

For any specific data cut or any specific market analysis, Research Impact's Custom Research Services are designed to support companies through the most important business decisions. Stay Focused! Save Time! Grow your Revenues!

For strategic market research and exclusive custom research, Research Impact Technologies can be contacted at 
contactus@researchimpact.com 

About Research Impact

Research Impact Technologies is a premier source of market research on several life science related sectors. The company emphasizes on factual insights and forecasts with maximum global coverage. Research Impact is constantly monitoring the biotechnology & Healthcare industry, tracking market trends, and forecasting industry based on specialized analysis. The life sciences sector is an ever growing marketplace with emerging technologies in areas of discovery, design and development. The company's product portfolio includes extensive market insight reports, company insight reports, country reports, and exclusive data tables. Customized to customer needs and requirements, custom research reports are extremely focused, with great importance given to deadlines and budget. RI Technologies strives to provide diligent market research reports that empower customers with enlightening critical business information.
Anasuya Vemuri
Research Impact Technologies
+91 9676994272